Blood Agar Validation for Susceptibility Testing of Isoniazid, Rifampicin, Ethambutol, and Streptomycin to Mycobacterium tuberculosis Isolates

Coban, Ahmet Yilmaz
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
In recent studies, it was shown that blood agar can be used at least as effectively as Löwenstein-Jensen medium for growing Mycobacterium tuberculosis. It was also shown that susceptibility testing can be performed on blood agar. Additional validation of blood agar was performed on regional M. tuberculosis isolates from Turkey to determine critical concentrations of isoniazid (INH), rifampicin (RIF), ethambutol (ETM), and streptomycin (STR). In the current study, 40 M. tuberculosis clinical isolates were tested. H37Rv, which is susceptible to all antituberculosis agents, ATCC 35822 (INH-resistant), ATCC 35838 (RIF-resistant), ATCC 35837 (ETM-resistant), and ATCC 35820 (STR-resistant) quality control strains were used as control strains. Proportion method on 7H11 agar was considered as gold standard in the study. MIC values of the control strains and clinical isolates were detected on blood and 7H11 agar. Categorical agreements were 100% for each antibiotic, and essential agreements were 100%, 97.5%, 82.5%, and 95% for INH, RIF, ETM, and STR, respectively. According to the data, 0.2 µg/mL for INH, 1 µg/mL for RIF, 4 µg/mL for ETM, and 2 µg/mL for STR were appropriate breakpoint values for susceptibility testing on blood agar. Blood agar may be recommended for use in both developed and developing countries for the susceptibility testing of M. tuberculosis isolates to primary antituberculosis drugs.


Related Articles

  • Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates. Sch�nfeld, Nicolas; Bergmann, Thorsten; Vesenbeckh, Silvan; Mauch, Harald; Bettermann, Gudrun; Bauer, Torsten T.; R�ssmann, Holger // Lung India;Oct-Dec2012, Vol. 29 Issue 4, p309 

    Context: The treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is consistently difficult. Besides resistances, drug availability can be problematic and costs for therapy are high. Aims: Our aim was to evaluate alternatives in treatment of MDR and XDR...

  • Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre. Azura, S.; Hussin, S.; Rahman, Md. Mostafizur // Pakistan Journal of Medical Sciences;Oct2011, Vol. 27 Issue 5, p1107 

    Objective: The prime objective of the study was to evaluate drug resistance and susceptibility of Mycobacterium tuberculosis isolated at University Kebangsaan Malaysia Medical Centre. Methodology: A total number of 726 specimens in the form of sputum and bronchial lavage obtained from patients...

  • Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance. Bobadilla-del Valle, Miriam; Torres-González, Pedro; Cervera-Hernández, Miguel Enrique; Martínez-Gamboa, Areli; Crabtree-Ramirez, Brenda; Chávez-Mazari, Bárbara; Ortiz-Conchi, Narciso; Rodríguez-Cruz, Luis; Cervantes-Sánchez, Axel; Gudiño-Enríquez, Tomasa; Cinta-Severo, Carmen; Sifuentes-Osornio, José; Ponce de León, Alfredo // PLoS Neglected Tropical Diseases;09/30/2015, Vol. 9 Issue 10, p1 

    Background: Mycobacterium tuberculosis causes the majority of tuberculosis (TB) cases in humans; however, in developing countries, human TB caused by M. bovis may be frequent but undetected. Human TB caused by M. bovis is considered a zoonosis; transmission is mainly through consumption of...

  • Pyrazinamide monoresistance in clinical isolates. KALIR, Nezaket; ÖZKÜTÜK, Ayşe Aydan; ESEN, Nuran; ÖZKÜTÜK, Nuri // Turkish Journal of Medical Sciences;Feb2013, Vol. 43 Issue 1, p163 

    Aim: To determine pyrazinamide (PZA) monoresistance in clinical isolates of My cob acterium tuberculosis complex (MTBC) isolated in hospitals in and around Ä°zmir. Materials and methods: The study was performed between 2004 and 2009 with 150 streptomycin, isoniazid, rifampicin, and ethambutol...

  • Comparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in Nigeria. Lawson, Lovett; Emenyonu, Nanmdi; Abdurrahman, Saddiq T.; Lawson, Juliana O.; Uzoewulu, Gertrude N.; Sogaolu, Olumide M.; Ebisike, Juliana N.; Parry, Christopher M.; Yassin, Mohammed A.; Cuevas, Luis E. // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background: This study compares Mycobacterium tuberculosis culture isolation and drug sensitivity testing (DST) using solid (LJ) and liquid (BACTEC-MGIT-960) media in Nigeria. Methods: This was a cross sectional survey of adults attending reference centres in Abuja, Ibadan and Nnewi with a new...

  • Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis. Lilienkampf, Annamaria; Pieroni, Marco; Franzblau, Scott G.; Bishai, William R.; Kozikowski, Alan P. // Current Topics in Medicinal Chemistry;Apr2012, Vol. 12 Issue 7, p729 

    New antituberculosis (anti-TB) drugs are urgently needed to battle drug-resistant Mycobacterium tuberculosis (Mtb) strains and to shorten the long treatment regimen. A series of isoxazole-based compounds, bearing a carboxy moiety at the C3 position, are highly potent and versatile anti-TB...

  • Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. Chaoui, Imane; Sabouni, Radia; Kourout, Moussa; Jordaan, Annemie M.; Lahlou, Ouafae; Elouad, Rajae; Akrim, Mohammed; Victor, Thomas C.; Elmzibri, Mohammed // Journal of Infection in Developing Countries;2009, Vol. 3 Issue 4, p278 

    Background: Drug-resistant tuberculosis is a major problem worldwide. Based on the knowledge of specific mutations occurring in Mycobacterium tuberculosis genome, drug resistance can be detected earlier. The aim of this study was to determine the prevalence of the most common mutations...

  • Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: A 4-year experience. Maurya, A. K.; Singh, A. K.; Kumar, M.; Umrao, J.; Kant, S.; Nag, V. L.; Kushwaha, R. A. S.; Dhole, T. N. // Indian Journal of Medical Microbiology;Jan-Mar2013, Vol. 31 Issue 1, p40 

    India has a high burden of drug-resistant tuberculosis (TB), although there is little data on multidrug-resistant tuberculosis (MDR-TB). Although MDR-TB has existed for long time in India, very few diagnostic laboratories are well-equipped to test drug sensitivity. The objectives of this study...

  • DRUG SUSCEPTIBILITY PROFILES OF MYCOBACTERIUM TUBERCULOSIS ISOLATES AT MANGALORE. Bhat, Sevitha; Radhakrishna, M.; Kotian, Mohan; Rao, Sunil // Indian Journal of Medical Sciences;Mar2010, Vol. 64 Issue 3, p99 

    BACKGROUND AND OBJECTIVES: Tuberculosis (TB) remains one of the major causes of death from a single infectious agent worldwide. Its resurgence in 1990s is primarily due to co-infection with HIV and the emergence of multi-drug-resistant (MDR) strains. Our objectives in this study were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics